Clinical Trials Logo

Sodium Oxybate clinical trials

View clinical trials related to Sodium Oxybate.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00123578 Terminated - Clinical trials for Substance-Related Disorders

GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1

Start date: August 2004
Phase: Phase 1/Phase 2
Study type: Interventional

Gamma hydroxybutyrate (GHB) is a powerful central nervous system depressant. The number of individuals seeking treatment for GHB abuse has been steadily increasing in the United States. Currently, lorazepam and pentobarbital are two medications used to treat individuals who experience GHB-withdrawal symptoms. The purpose of this study is to describe the signs and symptoms of GHB withdrawal and to identify predictors of withdrawal severity. The study will also evaluate the safety and effectiveness of treatment with lorazepam versus pentobarbital for GHB detoxification.